
    
      -  Each treatment cycle lasts five weeks, during which time participants will come to the
           clinic to receive bortezomib intravenously once a week for the first 4 weeks. Prednisone
           will be taken orally on a daily basis and dose reduction may be initiated after 1 cycle
           of therapy.

        -  During all treatment cycles, participants will have the following: physical exam and
           blood work. At the end of cycle 3 (week 15) the participants cGVHD will be evaluated.
           These assessments may include an eye examination, a skin examination, a pulmonary
           function test and/or, a flexion assessment test.

        -  Participants will receive 3 cycles of bortezomib.
    
  